As of 3:59pm ET
| -0.99 / -1.20%|
The 6 analysts offering 12-month price forecasts for GW Pharmaceuticals PLC have a median target of 149.50, with a high estimate of 165.00 and a low estimate of 40.00. The median estimate represents a +83.35% increase from the last price of 81.54.
The current consensus among 6 polled investment analysts is to Buy stock in GW Pharmaceuticals PLC. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.